Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Elang Mahkota Teknologi Tbk. (EMTK) vs Tempo Scan Pacific Tbk. (TSPC)

Elang Mahkota Teknologi Tbk.Trading
Tempo Scan Pacific Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Elang Mahkota Teknologi Tbk. dan Tempo Scan Pacific Tbk.: Elang Mahkota Teknologi Tbk. diperdagangkan di Rp510 (kapitalisasi pasar 31,02 T, volume 24 jam 24,97 jt), sedangkan Tempo Scan Pacific Tbk. diperdagangkan di Rp2.790 (kapitalisasi pasar 12,58 T, volume 24 jam 809,6 rb). Perbedaan utamanya: Elang Mahkota Teknologi Tbk. jauh lebih besar — sekitar 2,5× kapitalisasi pasar Tempo Scan Pacific Tbk., dan Elang Mahkota Teknologi Tbk. lebih aktif diperdagangkan (24,97 jt vs 809,6 rb). Mana yang lebih baik tergantung tujuan investasimu.

EMTKTSPC
Kapitalisasi Pasar
31,02 T12,58 T
Volume
24,97 jt809,6 rb
Lot
249,75 rb8,1 rb
Perputaran
12,72 M2,26 M
Harga Rata-rata
509,272.786,16
Nilai Transaksi
12,72 M2,26 M
Harga Ekuilibrium Indikatif
5102.790
Volume Ekuilibrium Indikatif
33,34 rb1,63 rb

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

EMTK
Lihat detail
TSPC
Lihat detail

Tentang Elang Mahkota Teknologi Tbk.

PT Elang Mahkota Teknologi Tbk (the Company) was established based on Notarial Deed No.7 dated August 3, 1983 of Soetomo Ramelan, S.H.. The Company is engaged in services, specifically in providing technology, media, and telecommunication services, trading, construction, and industry. Company started its commercial operation in 1984.

Selengkapnya di halaman EMTK

Tentang Tempo Scan Pacific Tbk.

PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.

Selengkapnya di halaman TSPC